Skip to main content
Equibles

Blue Owl Capital Holdings LP

Position in SGMT — Sagimet Biosciences Inc.

CIK 1858703 New York, NY
Back to SGMT Full portfolio

Position in SGMT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$9,744,005
+$7,999,498 QoQ
Shares Held
1,260,544
+277.5% QoQ
Ownership
2.03%
of shares outstanding
% of Portfolio
1.48%
of 13F equity value
Holder Rank
#14
of 122 holders
Holding Since
Dec 2023
11 quarters on record

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Blue Owl Capital Holdings LP holds $278,984,828 across 29 Biotechnology names. SGMT ranks #6 (3.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AKTS
Aktis Oncology, Inc.
 3,070,219 $98,953,158
2 CGEM
Cullinan Therapeutics, Inc.
 1,539,764 $28,039,102
3 LRMR
Larimar Therapeutics, Inc.
 9,163,157 $27,947,628
4 MPLT
MapLight Therapeutics, Inc.
 729,929 $26,160,655
5 EYPT
EyePoint, Inc.
 762,594 $10,905,094
6 SGMT
Sagimet Biosciences Inc.
This page 		1,260,544 $9,744,005
7 CRVS
Corvus Pharmaceuticals, Inc.
 608,600 $9,092,484
8 ARTV
Artiva Biotherapeutics, Inc.
 874,542 $8,483,057

All Filings in SGMT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,744,005 1,260,544
2026-03-31 $1,744,507 333,877
2025-12-31 $7,363,751 1,243,877
2025-09-30 $9,112,487 1,328,351
2025-06-30 $10,122,033 1,328,351
2025-03-31 $4,330,424 1,328,351
2024-12-31 $5,957,446 1,323,877
2024-09-30 $4,636,639 1,673,877
2024-06-30 $5,724,659 1,673,877
2024-03-31 $9,072,413 1,673,877
2023-12-31 $1,926,143 355,377